Ready-to-use injectable products require no further dilution or reconstitution before transfer to an administration device. For example, a sterile liquid medicine in a glass vial, in the required concentration, only needs to be drawn up into a syringe and therefore reduces the potential for errors to occur.
Advantages of ready-to-use solutions:
• delivery of the right drug in the right concentration and in the right presentation
• reducing risk of medication errors
• reducing risk of contamination
• improving patient safety
• reducing workload for nursing staff, releasing time for patient care
With a keen focus on patient safety, hameln has developed a range of standardised drug infusion concentrations for use in intensive care units, in line with the Intensive Care Society’s recommendations on standard medication infusion concentrations in critical care areas1:
1 Infusion medication concentrations in UK’s critical care areas: Are the Intensive Care Society’s recommendations being used? Titiesari Y, Barton G, Borthwick M, Keeling S, Keeling P. J Intensive Care Soc 2017, Vol. 18(1) 30–35
hameln is a leading supplier of high quality generic injectable medicines, specialising in critical care. Our portfolio contains a variety of products, ranging from water for injections to sedatives, anaesthetics, analgesics and antidotes. Everything we do is driven by the understanding we are all patients.